Upton Highlights Importance of FDA Reform Act to American Job Creators
May 31, 2012
Congressman Fred Upton (R-St. Joseph) joined House Republican Leadership to discuss the continued efforts of House Republicans to support American job creation and economic growth. Upton highlighted the House's passage of the Food and Drug Administration (FDA) Reform Act of 2012 (H.R. 5651), which passed by an overwhelmingly bipartisan vote of 387 to 5. H.R. 5651 will reauthorize and expand the FDA's user fee programs for medical products and includes major reforms to help U.S. manufacturers bring their life-saving products to patients and healthcare providers faster while maintaining the highest levels of patient safety. Michigan manufacturers like Perrigo, Pfizer, and Stryker have been put a competitive disadvantage because of the lack of predictability in the current FDA evaluation and approval process. H.R. 5651 will help these and other U.S. companies continue to lead the world in medical innovation and job creation. Reform will also significantly improve U.S. patient care by ensuring lifesaving products are brought to market in a timely manner.